Insurance access and demand response: Pricing and welfare implications

Area of Science:

• Health economics
• Pharmaceutical pricing
• Insurance market dynamics

Background:

• Liquidity-constrained patients face barriers to accessing unaffordable medical treatments.
• Monopolistic pricing strategies in the healthcare sector are a significant concern.
• The relationship between health insurance coverage and pharmaceutical pricing requires further economic modeling.

Purpose of the Study:

• To develop an economic model analyzing the impact of health insurance on treatment accessibility and pricing.
• To investigate how health insurance influences a monopolist's pricing decisions for medical treatments.
• To provide an economic rationale for observed pharmaceutical pricing strategies.

Main Methods:

• A theoretical economic model was developed to simulate patient access to treatments under different insurance scenarios.
• The model analyzed profit-maximizing pricing strategies of a monopolist provider.
• The study examined the effects of cost-sharing mechanisms and expanded insurance coverage on prices and consumer surplus.

Main Results:

• Health insurance enables liquidity-constrained patients to access otherwise unaffordable treatments.
• A monopolist sets higher prices for insured treatments compared to non-insured ones, even with cost-sharing.
• Consumer surplus may decrease under such insurance and pricing structures.
• The model offers an economic explanation for pharmaceutical prices exceeding product-derived value.
• Increased insurance coverage for monopoly-provided services exacerbates pricing issues.

Conclusions:

• Health insurance, while improving access, can inadvertently lead to higher treatment costs due to monopolistic pricing.
• The findings challenge standard moral hazard models, highlighting a distinct mechanism driving prices.
• The study provides a theoretical basis for concerns about pharmaceutical firms setting prices above treatment value.
• Policy implications suggest careful consideration of insurance design and market structures for monopoly-provided services.